These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


242 related items for PubMed ID: 9032295

  • 21. Activins and inhibins and their signaling.
    Vale W, Wiater E, Gray P, Harrison C, Bilezikjian L, Choe S.
    Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
    [Abstract] [Full Text] [Related]

  • 22. Inhibin interferes with activin signaling at the level of the activin receptor complex in Chinese hamster ovary cells.
    Martens JW, de Winter JP, Timmerman MA, McLuskey A, van Schaik RH, Themmen AP, de Jong FH.
    Endocrinology; 1997 Jul; 138(7):2928-36. PubMed ID: 9202237
    [Abstract] [Full Text] [Related]

  • 23. Roles of pathway-specific and inhibitory Smads in activin receptor signaling.
    Lebrun JJ, Takabe K, Chen Y, Vale W.
    Mol Endocrinol; 1999 Jan; 13(1):15-23. PubMed ID: 9892009
    [Abstract] [Full Text] [Related]

  • 24. Co-ordinate expression of activin A and its type I receptor mRNAs during phorbol ester-induced differentiation of human K562 erythroleukemia cells.
    Hildén K, Tuuri T, Erämaa M, Ritvos O.
    Mol Cell Endocrinol; 1999 Jul 20; 153(1-2):137-45. PubMed ID: 10459861
    [Abstract] [Full Text] [Related]

  • 25. Is the action of inhibin mediated via a unique receptor?
    Robertson DM, Hertan R, Farnworth PG.
    Rev Reprod; 2000 Sep 20; 5(3):131-5. PubMed ID: 11006162
    [Abstract] [Full Text] [Related]

  • 26. The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm.
    Bhushan A, Lin HY, Lodish HF, Kintner CR.
    Mol Cell Biol; 1994 Jun 20; 14(6):4280-5. PubMed ID: 8196664
    [Abstract] [Full Text] [Related]

  • 27. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
    Franzén A, Piek E, Westermark B, ten Dijke P, Heldin NE.
    Endocrinology; 1999 Sep 20; 140(9):4300-10. PubMed ID: 10465304
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of vascular endothelial cell growth by activin-A.
    McCarthy SA, Bicknell R.
    J Biol Chem; 1993 Nov 05; 268(31):23066-71. PubMed ID: 8226823
    [Abstract] [Full Text] [Related]

  • 29. Inactivation of activin-dependent transcription by kinase-deficient activin receptors.
    Tsuchida K, Vaughan JM, Wiater E, Gaddy-Kurten D, Vale WW.
    Endocrinology; 1995 Dec 05; 136(12):5493-503. PubMed ID: 7588300
    [Abstract] [Full Text] [Related]

  • 30. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis.
    Vänttinen T, Liu J, Kuulasmaa T, Kivinen P, Voutilainen R.
    J Endocrinol; 2003 Sep 05; 178(3):479-89. PubMed ID: 12967339
    [Abstract] [Full Text] [Related]

  • 31. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
    Ebner R, Chen RH, Lawler S, Zioncheck T, Derynck R.
    Science; 1993 Nov 05; 262(5135):900-2. PubMed ID: 8235612
    [Abstract] [Full Text] [Related]

  • 32. Characterization of type I receptors for transforming growth factor-beta and activin.
    ten Dijke P, Yamashita H, Ichijo H, Franzén P, Laiho M, Miyazono K, Heldin CH.
    Science; 1994 Apr 01; 264(5155):101-4. PubMed ID: 8140412
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms of inhibin signal transduction.
    Bernard DJ, Chapman SC, Woodruff TK.
    Recent Prog Horm Res; 2001 Apr 01; 56():417-50. PubMed ID: 11237224
    [Abstract] [Full Text] [Related]

  • 34. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
    Macías-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL.
    J Biol Chem; 1998 Oct 02; 273(40):25628-36. PubMed ID: 9748228
    [Abstract] [Full Text] [Related]

  • 35. Overexpression of activin A in stage IV colorectal cancer.
    Wildi S, Kleeff J, Maruyama H, Maurer CA, Büchler MW, Korc M.
    Gut; 2001 Sep 02; 49(3):409-17. PubMed ID: 11511564
    [Abstract] [Full Text] [Related]

  • 36. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.
    Attisano L, Cárcamo J, Ventura F, Weis FM, Massagué J, Wrana JL.
    Cell; 1993 Nov 19; 75(4):671-80. PubMed ID: 8242742
    [Abstract] [Full Text] [Related]

  • 37. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
    Bondestam J, Kaivo-oja N, Kallio J, Groome N, Hydén-Granskog C, Fujii M, Moustakas A, Jalanko A, ten Dijke P, Ritvos O.
    Mol Cell Endocrinol; 2002 Sep 30; 195(1-2):79-88. PubMed ID: 12354674
    [Abstract] [Full Text] [Related]

  • 38. Activin-related proteins in bovine mammary gland: localization and differential expression during gestational development and differentiation.
    Bloise E, Cassali GD, Ferreira MC, Ciarmela P, Petraglia F, Reis FM.
    J Dairy Sci; 2010 Oct 30; 93(10):4592-601. PubMed ID: 20854993
    [Abstract] [Full Text] [Related]

  • 39. Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line.
    Ying SY, Zhang Z.
    Breast Cancer Res Treat; 1996 Oct 30; 37(2):151-60. PubMed ID: 8750582
    [Abstract] [Full Text] [Related]

  • 40. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U, Souchelnytskyi S, Franzén P, Miyazono K, ten Dijke P, Heldin CH.
    J Biol Chem; 1997 Aug 22; 272(34):21187-94. PubMed ID: 9261125
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.